These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 27067607)

  • 1. Crystalline mesophases: Structure, mobility, and pharmaceutical properties.
    Shalaev E; Wu K; Shamblin S; Krzyzaniak JF; Descamps M
    Adv Drug Deliv Rev; 2016 May; 100():194-211. PubMed ID: 27067607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of amorphous and nanocrystalline solids from their X-ray diffraction patterns.
    Bates S; Zografi G; Engers D; Morris K; Crowley K; Newman A
    Pharm Res; 2006 Oct; 23(10):2333-49. PubMed ID: 17021963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermotropic liquid crystalline drugs.
    Bunjes H; Rades T
    J Pharm Pharmacol; 2005 Jul; 57(7):807-16. PubMed ID: 15969938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.
    Alie J; Menegotto J; Cardon P; Duplaa H; Caron A; Lacabanne C; Bauer M
    J Pharm Sci; 2004 Jan; 93(1):218-33. PubMed ID: 14648651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-ray diffraction, calorimetric, and dielectric relaxation study of the amorphous and smectic states of a main chain liquid crystalline polymer.
    Encinar M; Martínez-Gómez A; Rubio RG; Pérez E; Bello A; Prolongo MG
    J Phys Chem B; 2012 Aug; 116(32):9846-59. PubMed ID: 22835222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical considerations for the qualitative and quantitative determination of process-induced disorder in crystalline solids.
    Newman A; Zografi G
    J Pharm Sci; 2014 Sep; 103(9):2595-2604. PubMed ID: 24623166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A material science perspective of pharmaceutical solids.
    Cui Y
    Int J Pharm; 2007 Jul; 339(1-2):3-18. PubMed ID: 17537600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Process induced disorder in crystalline materials: differentiating defective crystals from the amorphous form of griseofulvin.
    Feng T; Pinal R; Carvajal MT
    J Pharm Sci; 2008 Aug; 97(8):3207-21. PubMed ID: 17990307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and mesomorphic properties of rigid-core ionic liquid crystals.
    Kouwer PH; Swager TM
    J Am Chem Soc; 2007 Nov; 129(45):14042-52. PubMed ID: 17949091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermotropic liquid crystals based on extended 2,5-disubstituted-1,3,4-oxadiazoles: structure-property relationships, variable-temperature powder X-ray diffraction, and small-angle X-ray scattering studies.
    Han J; Chui SS; Che CM
    Chem Asian J; 2006 Dec; 1(6):814-25. PubMed ID: 17441124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relaxation Dynamics vs Crystallization Kinetics in the Amorphous State: The Case of Stiripentol.
    Ruiz GN; Romanini M; Barrio M; Tamarit JL; Pardo LC; Macovez R
    Mol Pharm; 2017 Nov; 14(11):3636-3643. PubMed ID: 28915351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics simulation of amorphous indomethacin.
    Xiang TX; Anderson BD
    Mol Pharm; 2013 Jan; 10(1):102-14. PubMed ID: 23116319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-phase crystal disorder in pharmaceutical solids and its implication for solid-state stability.
    Clawson JS; Kennedy-Gabb S; Lee AY; Copley RC
    J Pharm Sci; 2011 Oct; 100(10):4302-16. PubMed ID: 21590691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glassiness of thermotropic liquid crystals across the isotropic-nematic transition.
    Chakrabarti D; Bagchi B
    J Phys Chem B; 2007 Oct; 111(40):11646-57. PubMed ID: 17880203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical liquid crystals: the relevance of partially ordered systems.
    Stevenson CL; Bennett DB; Lechuga-Ballesteros D
    J Pharm Sci; 2005 Sep; 94(9):1861-80. PubMed ID: 16052511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PH-induced nanosegregation of ritonavir to lyotropic liquid crystal of higher solubility than crystalline polymorphs.
    Rodríguez-Spong B; Acciacca A; Fleisher D; Rodríguez-Hornedo N
    Mol Pharm; 2008; 5(6):956-67. PubMed ID: 19434919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferroelectric Nematic and Ferrielectric Smectic Mesophases in an Achiral Bent-Core Azo Compound.
    Kumar J; Prasad V
    J Phys Chem B; 2018 Mar; 122(11):2998-3007. PubMed ID: 29485879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictions of onset of crystallization from experimental relaxation times I-correlation of molecular mobility from temperatures above the glass transition to temperatures below the glass transition.
    Bhugra C; Shmeis R; Krill SL; Pikal MJ
    Pharm Res; 2006 Oct; 23(10):2277-90. PubMed ID: 16933094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the solid-state properties of crystalline lysozyme during pharmaceutical unit-operations.
    Mohammad MA; Grimsey IM; Forbes RT
    J Pharm Biomed Anal; 2015 Oct; 114():176-83. PubMed ID: 26068908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.